This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
The historical rank and industry rank for Progressive Care's Median PS Value or its related term are showing as below:
RXMD'
s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.42 Med: 0.85 Max: 3.16
Current: 0.48
During the past 13 years, the highest Price to Median PS Value of Progressive Care was 3.16. The lowest was 0.42. And the median was 0.85.
RXMD's Price-to-Median-PS-Value is ranked better than 81.67% of 240
companies
in the Healthcare Providers & Services industry
Industry Median: 0.73
vs RXMD: 0.48
Progressive Care Median PS Value Historical Data
The historical data trend for Progressive Care's Median PS Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Progressive Care's Median PS Value
For the Pharmaceutical Retailers subindustry, Progressive Care's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Progressive Care's Price-to-Median-PS-Value Distribution in the Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Progressive Care's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where Progressive Care's Price-to-Median-PS-Value falls into.
10-Year Median PS Ratio is 0.4561.
Progressive Care's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $9.275.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Progressive Care (OTCPK:RXMD) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
Progressive Care's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
2.05
/
4.23
=
0.48
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Progressive Care Median PS Value Related Terms
Thank you for viewing the detailed overview of Progressive Care's Median PS Value provided by GuruFocus.com. Please click on the following links to see related term pages.
Progressive Care (Progressive Care) Business Description
Progressive Care Inc is a personalized healthcare services and technology company which provides prescription pharmaceutical services, risk management, and data analytics to healthcare organizations and providers. The company through its wholly-owned subsidiary Pharmco, provides prescription pharmaceuticals, compounded medications, tele-pharmacy services, anti-retroviral medications, medication therapy management, the supply of prescription medications to long-term care facilities, and health practice risk management. It also offers certain disease testing and vaccinations. It offers services in a variety of languages, including English, Spanish, French, Creole, Portuguese, Ukrainian, and Russian.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
RXMD has been successfully added to your 